Glenmark Switzerland

Last updated: 04.04.2017

Logo (2)

Glenmark Pharmaceuticals S.A. is a R&D centre focused on biologics established in 2004. It is a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd. (India). The biologics research centre focuses on discovery and development of novel biological entities, comprising of monoclonal antibody products targeted towards oncology and inflammation disease areas. The unit has all capabilities required to develop antibody products and take them rapidly from early discovery to clinical phase testing.


Street: Chemin de la Combeta 5

ZIP: 2300

City: La Chaux-de-Fonds

Phone: +41 32 729 35 50

Fax: +41 32 729 35 60




We use cookies to ensure that we give you the best experience on our site. For more info click here